Investing Profile

Anja Konig

VCInvestor

Global Head Novartis Venture Fund

nvfund.comBasel, Switzerland
Photo of Anja Konig, Managing Director at Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Novartis Venture Fund Managing Director
$100K - $5.0M
$1.5M
13
$750M
CompanyStageDateRound SizeTotal Raised
Bicycle Therapeutics
Series BJun 2017$52M
Series AOct 2014$32M
Venture RoundDec 2012£3.8M
Seed RoundOct 2009
$84M
£3.8M
Co-investors: Bruce Booth (Atlas Venture), Deborah Harland (SR One), Dr. Regina Hodits (Wellington Partners)
F2G
Private Equity RoundJun 2016$60M
Venture RoundSep 2012$30M
$90M
Co-investors: Raj Parekh (Advent Life Sciences), Maha Katabi (Sofinnova Investments)
Nabriva Therapeutics
Series BApr 2015$120M
$120M
Forendo Pharma
Series AOct 2014€12M
€12M
Co-investors: Hakan Goker (M Ventures (Merck))
Covagen
Series BDec 2013C59M
Series ANov 2010$6.3M
$6.3M
CHF59M
Co-investors: Abraham Kometz (Deerfield Management)
Oxagen
Series CNov 2009$27M
$27M
PharmAbcine
Series ASep 2009$6M
$6M
Diagnoplex
Series ADec 2008$8.3M
$8.3M
CHF1.3M
Co-investors: Thomas Goebel (Omega Funds)